Navigation Links
Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
Date:10/14/2010

cal degree from the University of Missouri-Columbia. Upon completing her internship at St. John's Mercy Medical Center, Dr. Gehrs finished her post graduate education by completing a residency and fellowship (vitreoretina) at Duke University Eye Center prior to becoming Chief Resident in 1993.

Dr. Gehrs specializes in retina/vitreous diseases and focuses her research in diabetic retinopathy and age-related macular degeneration. She is certified in both the National Board of Medical Examiners and the American Board of Ophthalmology. Dr. Gehrs is an accomplished teacher, frequent lecturer and is very active in several professional associations.

After more than a dozen years as a vitreoretinal faculty member at the University of Iowa, Dr. Gehrs joined the Center for Retina and Macular Disease, in Florida, in 2009. Most recently, Dr. Gehrs has been distinguished as one of the Best Doctors in America for the past four years in a row.

For full biographies on the members of the Ophthalmology clinical advisory board please see http://www.sequenom.com/Home/About-Us/Clinical-Advisory-Boards/Ophthalmology

"We welcome the strong research expertise and clinical experience that Drs. Hageman, Heier, and Gehrs bring to Sequenom's new ophthalmology focused clinical advisory board," said Ronald M. Lindsay, PhD, executive vice president of research and development at Sequenom. "These highly respected experts will play an important advisory role in supporting our diagnostic development programs and product commercialization plans."

About Sequenom Center for Molecular Medicine, LLC

Sequenom Center for Molecular Medicine (Sequenom CMM®) is a wholly-owned subsidiary of Sequenom, Inc., and is CAP accredited and CLIA-certified specialty reference laboratory dedicated to the development and commercialization of laboratory-developed genetic testing
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sequenom to Present at Two Financial Conferences in September
2. Sequenom to Present at Two Financial Conferences in March
3. Sequenom Appoints Two New Board Members
4. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
5. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
6. SEQUENOM Announces Launch of MassARRAY Compact 96 System
7. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
8. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
9. Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program
10. Fate Therapeutics Announces Collaboration With BD to Develop and Commercialize Induced Pluripotent Stem Cell Technology
11. Osteotech Announces Early Termination of HSR Waiting Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 Rancho BioSciences , the ... manually curated public data source TCGA for ... the data is now available for other oncology groups. ... and internal data sources for their Pharma, Government and ... the data that becomes more easily accessible. Rancho ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Whitehouse Laboratories ... its ICH Stability Testing and Package Test Capacity. Responding ... centers on a dramatic increase in environmental chamber storage ... stability, storage and aging samples to be securely held ... this major capital expenditure has already taken place with ...
(Date:10/30/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), ... present a company overview at the Nomura Biotechnology Conference on ... Boston, MA. A live webcast ... Media" section of the Company,s website, www.isispharm.com .  A ... hours and will be archived for a limited time. ...
(Date:10/30/2014)... challenges in the development of quantum technologies has been ... paper published today (28 October) in Nature Communications ... make a new type of flexibly designed microscopic trap ... sensors and specialised superfast computers, often depend on harnessing ... trapping these tiny particles are hugely problematic because of ...
Breaking Biology Technology:Rancho BioSciences Manually Curated TCGA Data Sets Available 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and ... announced that a supplemental New Drug Application (sNDA) has been ... the expanded use of BYETTA® (exenatide) injection as an add-on ... thiazolidinedione (TZD) in conjunction with diet and exercise for adults ...
... 22, 2010 Novavax, Inc. (Nasdaq: NVAX ... School, led by Dr. Trudy Morrison, published in the ... report indicating that a novel virus-like particle (VLP) vaccine ... a live virus challenge.  This vaccine candidate has been ...
... the University of Santiago de Compostela (USC) have analysed levels ... in Galicia. The results show that 34% of these schools ... Union. Excessive inhalation of radon is associated with lung cancer. ... taken, 34% had radon levels in excess of 400 Bequerels/m3 ...
Cached Biology Technology:Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 2Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 3Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 4Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 5Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 6Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin 7NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 434 percent of Galician secondary schools exceed maximum recommended radon levels 2
(Date:10/30/2014)... 2014 Biological membranes are mainly composed of lipid ... solution ions onto lipid membranes helps clarify functional ... provides a quantitative description of the equilibria between ... and Zbigniew Figaszewski from the University of Bialystok, ... these findings, just published in EPJ E ...
(Date:10/29/2014)... released by unconventional oil and gas production are well ... in the open access journal Environmental Health . ... found. The study is the first to be based ... sites and could be used to supplement official air-quality ... reserves that do not readily flow to the surface. ...
(Date:10/29/2014)... In the largest study of its kind to date, ... genes that heighten the risk for autism. Joseph Buxbaum, ... York City, Mark Daly, Ph.D., Broad Institute of Harvard ... DNA samples from affected children, parents and unrelated people. ... to contribute to the risk for autism spectrum disorder ...
Breaking Biology News(10 mins):Ion adsorption matter in biology 2Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3
... BiOptix announced continued support of the Colorado BioScience ... life sciences showcase event in Colorado to be ... continues to believe in the goals and community that is ... President and CEO of BiOptix.   "As Colorado continues to ...
... become more severe in the Southwest, trees are increasingly ... to middle elevations, University of Arizona researchers report in ... Journal of Geophysical Research Biogeosciences ., Lead author Jeremy ... of geosciences, said: "We know the climate in the ...
... study provides a first-time analysis of the value of forage ... and anchovies. Three kinds of contributions of forage fish were ... fish, and as an important link in the food web ... a total of $16.9 billion, as both direct catch and ...
Cached Biology News:BiOptix Participates in Leading Life Sciences Event BioWest 2012 2Droughts are pushing trees to the limit 2Droughts are pushing trees to the limit 3Droughts are pushing trees to the limit 4Study provides first-time analysis of 3 distinct contributions of forage fish worldwide 2Study provides first-time analysis of 3 distinct contributions of forage fish worldwide 3
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
... --- a cocktail of 3 siRNAs specifically ... our most popular product. The siTrio reagent ... of your target gene when used under ... and confirmation of optimal transfection with one ...
... with 96 x 0.2 ml reaction module ... applications. It is equipped with an interchangeable ... is compatible with optical modules for real-time ... by algorithm, block, or in-sample probe. It ...
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
Biology Products: